Upstream Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Upstream Bio, Inc. (UPB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income-62.81-20.54-23.87
Depreciation & Amortization0.090.060.01
Stock Based Compensation6.003.431.28
Change in Working Capital1.87-4.313.41
Change in Accounts Receivable-0.520.31-0.41
Change in Accounts Payable2.021.280.46
Change in Other Working Capital0.37-15.310.15
Other Operating Activities-2.68-15.310.15
Net Cash from Operating Activities-59.17-37.93-19.02
Investing Activities
Capital Expenditures-0.51-0.14-0.08
Purchases of Investments-58.97-128.990.00
Sales/Maturities of Investments231.6446.290.00
Net Cash from Investing Activities-59.49-82.84-0.08
Financing Activities
Common Stock Issued272.880.120.00
Other Financing Activities-3.970.00-0.04
Net Cash from Financing Activities418.91129.559.96
Summary
Net Change in Cash300.258.78-9.14
Cash at Beginning of Period25.8317.0526.19
Cash at End of Period326.0925.8317.05
Free Cash Flow-59.68-38.07-19.10